Should Concerta (methylphenidate extended-release) be prescribed with a monthly refill schedule?

Monthly Prescribing of Concerta: Required Due to Schedule II Status

Yes, Concerta (methylphenidate extended-release) must be prescribed on a monthly basis because it is a Schedule II controlled substance, which legally prohibits refills. 1

Legal Requirements for Schedule II Stimulants

The Schedule II classification of methylphenidate mandates specific prescribing practices:

• No refills are permitted on Schedule II controlled substance prescriptions 1
• Practitioners can write prescriptions on a monthly basis, and in some jurisdictions (such as New York State), prescriptions may be written for up to 3 months at a time, though each prescription must be dated for future dispensing 1
• This legal framework exists due to methylphenidate's abuse potential and DEA classification as a drug of abuse 1

Clinical Monitoring Schedule vs. Prescription Frequency

While monthly prescriptions are required by law, the frequency of actual clinical visits can be less frequent once patients are stabilized:

During Initial Titration Phase

• Weekly contact (by phone or in-person) during dose adjustments 1
• Typically requires 2-4 weeks for initial titration 1
• Follow-up appointments should be made at least monthly until symptoms are stabilized 1

During Maintenance Phase

Once stabilized on medication 1:

• Children with stable responses and no comorbidities can be seen once every 3-4 months
• Complex comorbidity or side effects may require monthly visits
• The MTA study demonstrated that once-monthly 30-minute medication visits resulted in significantly better outcomes compared to treatment as usual 1

Practical Implementation

The key distinction is between prescription frequency (monthly due to legal requirements) and visit frequency (can be every 3-4 months for stable patients):

1. For stable patients seen quarterly, you can provide three separate prescriptions at one visit, each dated for monthly dispensing 1
2. Between visits, monitoring can occur via telephone contact 1
3. Each visit should assess:
   • Target ADHD symptoms (from parents and teachers) 1
   • Side effects through specific questioning 1
   • Weight measurement 1
   • Blood pressure and heart rate 2

Important Caveats

More frequent visits are warranted when 1:

• Side effects are present
• Significant impairment from comorbid psychiatric disorders exists
• Problems with medication adherence occur
• The patient requires psychoeducation or psychosocial intervention
• During adolescence, when monitoring for diversion and misuse is critical 3

The requirement for monthly prescriptions reflects regulatory control rather than clinical necessity for monthly visits in all cases. However, the prescriber must balance legal compliance with appropriate clinical monitoring based on individual patient needs and stability.